Thesis offers customized nootropics that target key neurotransmitters and hormones to support cognitive function, focus, learning, motivation, memory, and stress resilience. It is described as the world's first personalized brain supplement brand.
- Category
- Nutraceuticals
- Stage
- Series A
- Employees
- 24
- HQ
- New York City, United States
- Founded
- 2017
- Funding
- $14M